Trending
Recently Published
How to disinfect if the stomach bug hits your home18.12.2025Norovirus can spread easily. Someone who was sick with the virus can spread it up to two weeks after feeling better.
The most effective method to Explore Moral Situations in Brain research with Your Certification17.10.2023The area of brain science frequently includes exploring touchy landscapes, won this page moral difficulties are a typical event. Experts with
Interstellar comet 3I/ATLAS will fly by Earth Friday. Here are the latest images19.12.2025Interstellar comet 3I/ATLAS will make its closest approach to Earth on Friday. New X-ray images could shed light on its composition.
13 must-see moon events in 2026: Eclipses, supermoons, conjunctions and more29.12.2025Here are the best lunar events to see in 2026, including eclipses, supermoons and conjunctions.
15 Outrageous Cosplay Outfits That Will Blow You Away04.12.2015Augue, announcement nec consectetur quis, elementum eu arcu. Nunc ornare arcu lacus, quis aliquet odio bibendum non. Nam vitae libero mauris. Suspendisse vitae purus ligula. Morbi sed diam eget dolor posuere convallis vel nisl. Nulla sagittis efficitur ex, at sodales massa pulvinar a. Nunc quis lacinia eros. Fusce ac ipsum gravida, tristique sed felis.
The race is on to turn your body into a GLP-1 factory04.11.2025People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories that churn out a protein that is essentially the active ingredient in drugs like Ozempic, Wegovy, Zepbound and Mounjaro.
Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals14.12.2025Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, various diseases and even the origin of life.
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients23.12.2025Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market. The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version.
















